Literature DB >> 18495425

Angina pectoris is a stronger indicator of diffuse vascular atherosclerosis than intermittent claudication: Framingham study.

W B Kannel1, J C Evans, S Piper, J M Murabito.   

Abstract

OBJECTIVE: To compare implications of Angina Pectoris (AP) and Intermittent Claudication (IC) as indicators of clinical atherosclerosis in other vascular territories. STUDY DESIGN AND
SETTING: Prospective cohort study of cardiovascular disease (CVD) in 5,209 men and women of Framingham, MA, aged 28-62 years at enrollment in 1948-1951, who received biennial examinations during the first 36 years of follow-up. Comparative 10-year incidence of subsequent atherosclerotic CVD in participants with IC and AP relative to a reference sample free of CVD was determined.
RESULTS: On follow-up, 95 CVD events occurred in 186 participants with IC and 206 of 413 with AP. After age, sex, and risk-factor adjustment, the proportion acquiring other CVD was 34.0% for IC and 43.4% for AP. Relative to the reference sample, those with IC had a 2.73-fold higher age and sex-adjusted 10-year hazard of CVD (95% CI 2.21, 3.38) and for AP was 3.17 (95% CI 2.73, 3.69). CVD hazard ratios remained more elevated for AP and statistically significant after standard risk factor adjustment. Risk factors accounted for more of the excess CVD risk associated with IC (34.8%) than AP (9.5%).
CONCLUSION: AP is as useful as IC as a hallmark of diffuse atherosclerotic CVD and an indication for comprehensive preventive measures.

Entities:  

Mesh:

Year:  2008        PMID: 18495425      PMCID: PMC3898849          DOI: 10.1016/j.jclinepi.2007.10.025

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  35 in total

1.  Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group.

Authors:  A B Newman; L Shemanski; T A Manolio; M Cushman; M Mittelmark; J F Polak; N R Powe; D Siscovick
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-03       Impact factor: 8.311

2.  Effect of simvastatin on ischemic signs and symptoms in the Scandinavian simvastatin survival study (4S).

Authors:  T R Pedersen; J Kjekshus; K Pyörälä; A G Olsson; T J Cook; T A Musliner; J A Tobert; T Haghfelt
Journal:  Am J Cardiol       Date:  1998-02-01       Impact factor: 2.778

3.  Prediction of coronary heart disease using risk factor categories.

Authors:  P W Wilson; R B D'Agostino; D Levy; A M Belanger; H Silbershatz; W B Kannel
Journal:  Circulation       Date:  1998-05-12       Impact factor: 29.690

4.  Intermittent claudication in 8343 men and 21-year specific mortality follow-up.

Authors:  S J Bowlin; J H Medalie; S A Flocke; S J Zyzanski; S Yaari; U Goldbourt
Journal:  Ann Epidemiol       Date:  1997-04       Impact factor: 3.797

5.  Corrected group prognostic curves and summary statistics.

Authors:  I M Chang; R Gelman; M Pagano
Journal:  J Chronic Dis       Date:  1982

6.  Intermittent claudication. A risk profile from The Framingham Heart Study.

Authors:  J M Murabito; R B D'Agostino; H Silbershatz; W F Wilson
Journal:  Circulation       Date:  1997-07-01       Impact factor: 29.690

7.  Chest pain on questionnaire and prediction of major ischaemic heart disease events in men.

Authors:  F C Lampe; P H Whincup; S G Wannamethee; S Ebrahim; M Walker; A G Shaper
Journal:  Eur Heart J       Date:  1998-01       Impact factor: 29.983

8.  Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease.

Authors:  M M McDermott; S Mehta; H Ahn; P Greenland
Journal:  J Gen Intern Med       Date:  1997-04       Impact factor: 5.128

9.  Peripheral vascular disease: consequence for survival and association with risk factors in the Speedwell prospective heart disease study.

Authors:  D Bainton; P Sweetnam; I Baker; P Elwood
Journal:  Br Heart J       Date:  1994-08

10.  Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index.

Authors:  A B Newman; K Sutton-Tyrrell; M T Vogt; L H Kuller
Journal:  JAMA       Date:  1993-07-28       Impact factor: 56.272

View more
  5 in total

1.  Global quantification of pulmonary artery atherosclerosis using 18F-sodium fluoride PET/CT in at-risk subjects.

Authors:  Vincent Zhang; Austin J Borja; Chaitanya Rojulpote; Sayuri Padmanabhan; Shivaraj Patil; Karthik Gonuguntla; Mona-Elisabeth Revheim; Thomas J Werner; Poul F Høilund-Carlsen; Abass Alavi
Journal:  Am J Nucl Med Mol Imaging       Date:  2020-04-15

2.  Intermittent claudication: From its risk factors to its long-term prognosis in men. The Quebec Cardiovascular Study.

Authors:  A St-Pierre; B Cantin; B Lamarche; D Auger; Jean- Pierre Després; G R Dagenais
Journal:  Can J Cardiol       Date:  2010-01       Impact factor: 5.223

3.  One simple claudication question as first step in Peripheral Arterial Disease (PAD) screening: A meta-analysis of the association with reduced Ankle Brachial Index (ABI) in 27,945 subjects.

Authors:  Arne Georg Kieback; Christine Espinola-Klein; Claudia Lamina; Susanne Moebus; Daniel Tiller; Roberto Lorbeer; Andreas Schulz; Christa Meisinger; Daniel Medenwald; Raimund Erbel; Alexander Kluttig; Philipp S Wild; Florian Kronenberg; Knut Kröger; Till Ittermann; Marcus Dörr
Journal:  PLoS One       Date:  2019-11-04       Impact factor: 3.240

Review 4.  Cardiac autonomic testing and diagnosing heart disease. "A clinical perspective".

Authors:  Nicholas L DePace; Joy P Mears; Michael Yayac; Joseph Colombo
Journal:  Heart Int       Date:  2014-12-05

Review 5.  Hypoxia-Inducible Factor Regulates Endothelial Metabolism in Cardiovascular Disease.

Authors:  Karim Ullah; Rongxue Wu
Journal:  Front Physiol       Date:  2021-07-05       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.